Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001507650-26-000007

Co-Chief Executive Officer bought 3,810,000 shares at $13.12 ($49,987,200)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Mahkam · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-12 Purchase : show line 1 in the form +3,810,000 $13.12 $49,987,200 573,883,879 I
Open-market purchases · 3,810,000 sh · avg $13.12 · $49,987,200
Loading xslF345X06/wk-form4_1781289308.xml…